{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T11:17:22Z","timestamp":1791890242437,"version":"4.3.4"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,10,9]],"date-time":"2012-10-09T00:00:00Z","timestamp":1349740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2012,10,9]],"date-time":"2012-10-09T00:00:00Z","timestamp":1349740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1038\/leu.2012.294","type":"journal-article","created":{"date-parts":[[2012,10,10]],"date-time":"2012-10-10T16:00:31Z","timestamp":1349884831000},"page":"629-634","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["BCR-ABL1 kinase inhibits uracil DNA glycosylase UNG2 to enhance oxidative DNA damage and stimulate genomic instability"],"prefix":"10.1038","volume":"27","author":[{"given":"A","family":"Slupianek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Falinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Znojek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Stoklosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Flis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Doneddu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Pytel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Synowiec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Blasiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Bellacosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Skorski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,10,9]]},"reference":[{"key":"BFleu2012294_CR1","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/nrc2147","volume":"7","author":"JV Melo","year":"2007","unstructured":"Melo JV, Barnes DJ . Chronic myeloid leukaemia as a model of disease evolution in human cancer. Nat Rev Cancer 2007; 7: 441\u2013453.","journal-title":"Nat Rev Cancer"},{"key":"BFleu2012294_CR2","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1042\/CS20040336","volume":"109","author":"SB Marley","year":"2005","unstructured":"Marley SB, Gordon MY . Chronic myeloid leukaemia: stem cell derived but progenitor cell driven. Clin Sci 2005; 109: 13\u201325.","journal-title":"Clin Sci"},{"key":"BFleu2012294_CR3","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/ajh.21457","volume":"84","author":"L Foroni","year":"2009","unstructured":"Foroni L, Gerrard G, Nna E, Khorashad JS, Stevens D, Swale B et al. Technical aspects and clinical applications of measuring BCR-ABL1 transcripts number in chronic myeloid leukemia. Am J Hematol 2009; 84: 517\u2013522.","journal-title":"Am J Hematol"},{"key":"BFleu2012294_CR4","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s11899-011-0087-9","volume":"6","author":"DL White","year":"2011","unstructured":"White DL, Hughes TP . Predicting the response of CML patients to tyrosine kinase inhibitor therapy. Curr Hematol Malig Rep 2011; 6: 88\u201395.","journal-title":"Curr Hematol Malig Rep"},{"key":"BFleu2012294_CR5","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1016\/j.chembiol.2011.11.001","volume":"18","author":"T Skorski","year":"2011","unstructured":"Skorski T . BCR-ABL1 kinase: hunting an elusive target with new weapons. Chem Biol 2011; 18: 1352\u20131353.","journal-title":"Chem Biol"},{"key":"BFleu2012294_CR6","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1182\/blood-2005-03-1036","volume":"106","author":"SG Willis","year":"2005","unstructured":"Willis SG, Lange T, Demehri S, Otto S, Crossman L, Niederwieser D et al. High-sensitivity detection of BCR-ABL kinase domain mutations in imatinib-naive patients: correlation with clonal cytogenetic evolution but not response to therapy. Blood 2005; 106: 2128\u20132137.","journal-title":"Blood"},{"key":"BFleu2012294_CR7","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/leu.2011.187","volume":"26","author":"FX Gruber","year":"2012","unstructured":"Gruber FX, Ernst T, Porkka K, Engh RA, Mikkola I, Maier J et al. Dynamics of the emergence of dasatinib and nilotinib resistance in imatinib-resistant CML patients. Leukemia 2012; 26: 172\u2013177.","journal-title":"Leukemia"},{"key":"BFleu2012294_CR8","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1172\/JCI41246","volume":"120","author":"D Perrotti","year":"2010","unstructured":"Perrotti D, Jamieson C, Goldman J, Skorski T . Chronic myeloid leukemia: mechanisms of blastic transformation. J Clin Invest 2010; 120: 2254\u20132264.","journal-title":"J Clin Invest"},{"key":"BFleu2012294_CR9","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.bbrc.2004.08.169","volume":"323","author":"N Sorel","year":"2004","unstructured":"Sorel N, Bonnet ML, Guillier M, Guilhot F, Brizard A, Turhan AG . Evidence of ABL-kinase domain mutations in highly purified primitive stem cell populations of patients with chronic myelogenous leukemia. Biochem Biophys Res Commun 2004; 323: 728\u2013730.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFleu2012294_CR10","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1038\/leu.2008.78","volume":"22","author":"M Koptyra","year":"2008","unstructured":"Koptyra M, Cramer K, Slupianek A, Richardson C, Skorski T . BCR\/ABL promotes accumulation of chromosomal aberrations induced by oxidative and genotoxic stress. Leukemia 2008; 22: 1969\u20131972.","journal-title":"Leukemia"},{"key":"BFleu2012294_CR11","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/S0092-8674(01)00220-3","volume":"104","author":"P Schar","year":"2001","unstructured":"Schar P . Spontaneous DNA damage, genome instability, and cancer--when DNA replication escapes control. Cell 2001; 104: 329\u2013332.","journal-title":"Cell"},{"key":"BFleu2012294_CR12","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0027-5107(01)00091-4","volume":"477","author":"AL Jackson","year":"2001","unstructured":"Jackson AL, Loeb LA . The contribution of endogenous sources of DNA damage to the multiple mutations in cancer. Mutat Res 2001; 477: 7\u201321.","journal-title":"Mutat Res"},{"issue":"1","key":"BFleu2012294_CR13","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/j.1749-6632.2000.tb06182.x","volume":"899","author":"JOHN M.C. GUTTERIDGE","year":"2006","unstructured":"Gutteridge JM, Halliwell B . Free radicals and antioxidants in the year 2000. A historical look to the future. Ann NY Acad Sci 2000 899: 136\u2013147.","journal-title":"Annals of the New York Academy of Sciences"},{"key":"BFleu2012294_CR14","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1385\/CBB:35:2:141","volume":"35","author":"AL Lu","year":"2001","unstructured":"Lu AL, Li X, Gu Y, Wright PM, Chang DY . Repair of oxidative DNA damage: mechanisms and functions. Cell Biochem Biophys 2001; 35: 141\u2013170.","journal-title":"Cell Biochem Biophys"},{"key":"BFleu2012294_CR15","doi-asserted-by":"publisher","first-page":"6609","DOI":"10.1073\/pnas.91.14.6609","volume":"91","author":"DI Feig","year":"1994","unstructured":"Feig DI, Sowers LC, Loeb LA . Reverse chemical mutagenesis: identification of the mutagenic lesions resulting from reactive oxygen species-mediated damage to DNA. Proc Natl Acad Sci USA 1994; 91: 6609\u20136613.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2012294_CR16","doi-asserted-by":"publisher","first-page":"4253","DOI":"10.1182\/blood-2011-10-385658","volume":"119","author":"M Nieborowska-Skorska","year":"2012","unstructured":"Nieborowska-Skorska M, Kopinski PK, Ray R, Hoser G, Ngaba D, Flis S et al. Rac2-MRC-cIII-generated ROS cause genomic instability in chronic myeloid leukemia stem cells and primitive progenitors. Blood 2012; 119: 4253\u20134263.","journal-title":"Blood"},{"key":"BFleu2012294_CR17","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/em.1070","volume":"38","author":"S Mitra","year":"2001","unstructured":"Mitra S, Boldogh I, Izumi T, Hazra TK . Complexities of the DNA base excision repair pathway for repair of oxidative DNA damage. Environ Mol Mutagen 2001; 38: 180\u2013190.","journal-title":"Environ Mol Mutagen"},{"key":"BFleu2012294_CR18","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1093\/nar\/24.3.418","volume":"24","author":"M Dizdaroglu","year":"1996","unstructured":"Dizdaroglu M, Karakaya A, Jaruga P, Slupphaug G, Krokan HE . Novel activities of human uracil DNA N-glycosylase for cytosine-derived products of oxidative DNA damage. Nucleic Acids Res 1996; 24: 418\u2013422.","journal-title":"Nucleic Acids Res"},{"key":"BFleu2012294_CR19","doi-asserted-by":"publisher","first-page":"5291","DOI":"10.1093\/nar\/gkh859","volume":"32","author":"M Matsubara","year":"2004","unstructured":"Matsubara M, Tanaka T, Terato H, Ohmae E, Izumi S, Katayanagi K et al. Mutational analysis of the damage-recognition and catalytic mechanism of human SMUG1 DNA glycosylase. Nucleic Acids Res 2004; 32: 5291\u20135302.","journal-title":"Nucleic Acids Res"},{"key":"BFleu2012294_CR20","doi-asserted-by":"publisher","first-page":"42205","DOI":"10.1074\/jbc.M206884200","volume":"277","author":"M Takao","year":"2002","unstructured":"Takao M, Kanno S, Kobayashi K, Zhang QM, Yonei S, van der Horst GT et al. A back-up glycosylase in Nth1 knock-out mice is a functional Nei (endonuclease VIII) homologue. J Biol Chem 2002; 277: 42205\u201342213.","journal-title":"J Biol Chem"},{"key":"BFleu2012294_CR21","doi-asserted-by":"publisher","first-page":"30417","DOI":"10.1074\/jbc.C200355200","volume":"277","author":"TK Hazra","year":"2002","unstructured":"Hazra TK, Kow YW, Hatahet Z, Imhoff B, Boldogh I, Mokkapati SK et al. Identification and characterization of a novel human DNA glycosylase for repair of cytosine-derived lesions. J Biol Chem 2002; 277: 30417\u201330420.","journal-title":"J Biol Chem"},{"key":"BFleu2012294_CR22","doi-asserted-by":"publisher","first-page":"32422","DOI":"10.1074\/jbc.M004535200","volume":"275","author":"F Petronzelli","year":"2000","unstructured":"Petronzelli F, Riccio A, Markham GD, Seeholzer SH, Stoerker J, Genuardi M et al. Biphasic kinetics of the human DNA repair protein MED1 (MBD4), a mismatch-specific DNA N-glycosylase. J Biol Chem 2000; 275: 32422\u201332429.","journal-title":"J Biol Chem"},{"key":"BFleu2012294_CR23","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1098\/rstb.2008.0186","volume":"364","author":"T Visnes","year":"2009","unstructured":"Visnes T, Doseth B, Pettersen HS, Hagen L, Sousa MM, Akbari M et al. Uracil in DNA and its processing by different DNA glycosylases. Philos Trans R Soc Lond B Biol Sci 2009; 364: 563\u2013568.","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"BFleu2012294_CR24","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S0300-9084(99)80039-X","volume":"81","author":"S Boiteux","year":"1999","unstructured":"Boiteux S, Radicella JP . Base excision repair of 8-hydroxyguanine protects DNA from endogenous oxidative stress. Biochimie 1999; 81: 59\u201367.","journal-title":"Biochimie"},{"key":"BFleu2012294_CR25","doi-asserted-by":"publisher","first-page":"2576","DOI":"10.1158\/0008-5472.CAN-07-6858","volume":"68","author":"T Stoklosa","year":"2008","unstructured":"Stoklosa T, Poplawski T, Koptyra M, Nieborowska-Skorska M, Basak G, Slupianek A et al. BCR\/ABL inhibits mismatch repair to protect from apoptosis and induce point mutations. Cancer Res 2008; 68: 2576\u20132580.","journal-title":"Cancer Res"},{"key":"BFleu2012294_CR26","doi-asserted-by":"publisher","first-page":"4531","DOI":"10.1182\/blood.V99.12.4531","volume":"99","author":"M Nieborowska-Skorska","year":"2002","unstructured":"Nieborowska-Skorska M, Hoser G, Kossev P, Wasik MA, Skorski T . Complementary functions of the antiapoptotic protein A1 and serine\/threonine kinase pim-1 in the BCR\/ABL-mediated leukemogenesis. Blood 2002; 99: 4531\u20134539.","journal-title":"Blood"},{"key":"BFleu2012294_CR27","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S1097-2765(01)00357-4","volume":"8","author":"A Slupianek","year":"2001","unstructured":"Slupianek A, Schmutte C, Tombline G, Nieborowska-Skorska M, Hoser G, Nowicki MO et al. BCR\/ABL regulates mammalian RecA homologs, resulting in drug resistance. Mol Cell 2001; 8: 795\u2013806.","journal-title":"Mol Cell"},{"key":"BFleu2012294_CR28","doi-asserted-by":"publisher","first-page":"4189","DOI":"10.1128\/MCB.22.12.4189-4201.2002","volume":"22","author":"A Slupianek","year":"2002","unstructured":"Slupianek A, Hoser G, Majsterek I, Bronisz A, Malecki M, Blasiak J et al. Fusion tyrosine kinases induce drug resistance by stimulation of homology-dependent recombination repair, prolongation of G(2)\/M phase, and protection from apoptosis. Mol Cell Biol 2002; 22: 4189\u20134201.","journal-title":"Mol Cell Biol"},{"key":"BFleu2012294_CR29","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1158\/0008-5472.CAN-10-1066","volume":"71","author":"A Slupianek","year":"2011","unstructured":"Slupianek A, Poplawski T, Jozwiakowski SK, Cramer K, Pytel D, Stoczynska E et al. BCR\/ABL stimulates WRN to promote survival and genomic instability. Cancer Res 2011; 71: 842\u2013851.","journal-title":"Cancer Res"},{"key":"BFleu2012294_CR30","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1093\/nar\/11.5.1475","volume":"11","author":"JD Dignam","year":"1983","unstructured":"Dignam JD, Lebovitz RM, Roeder RG . Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 1983; 11: 1475\u20131489.","journal-title":"Nucleic Acids Res"},{"key":"BFleu2012294_CR31","doi-asserted-by":"publisher","first-page":"39926","DOI":"10.1074\/jbc.M207107200","volume":"277","author":"B Kavli","year":"2002","unstructured":"Kavli B, Sundheim O, Akbari M, Otterlei M, Nilsen H, Skorpen F et al. hUNG2 is the major repair enzyme for removal of uracil from U:A matches, U:G mismatches, and U in single-stranded DNA, with hSMUG1 as a broad specificity backup. J Biol Chem 2002; 277: 39926\u201339936.","journal-title":"J Biol Chem"},{"key":"BFleu2012294_CR32","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/0092-8674(95)90290-2","volume":"80","author":"CD Mol","year":"1995","unstructured":"Mol CD, Arvai AS, Slupphaug G, Kavli B, Alseth I, Krokan HE et al. Crystal structure and mutational analysis of human uracil-DNA glycosylase: structural basis for specificity and catalysis. Cell 1995; 80: 869\u2013878.","journal-title":"Cell"},{"key":"BFleu2012294_CR33","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S1383-5718(02)00289-9","volume":"535","author":"J Blasiak","year":"2003","unstructured":"Blasiak J, Gloc E, Drzewoski J, Wozniak K, Zadrozny M, Skorski T et al. Free radical scavengers can differentially modulate the genotoxicity of amsacrine in normal and cancer cells. Mutat Res 2003; 535: 25\u201334.","journal-title":"Mutat Res"},{"key":"BFleu2012294_CR34","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1182\/blood-2005-07-2815","volume":"108","author":"M Koptyra","year":"2006","unstructured":"Koptyra M, Falinski R, Nowicki MO, Stoklosa T, Majsterek I, Nieborowska-Skorska M et al. BCR\/ABL kinase induces self-mutagenesis via reactive oxygen species to encode imatinib resistance. Blood 2006; 108: 319\u2013327.","journal-title":"Blood"},{"key":"BFleu2012294_CR35","doi-asserted-by":"publisher","first-page":"8120","DOI":"10.1093\/nar\/gkq682","volume":"38","author":"G Sharbeen","year":"2010","unstructured":"Sharbeen G, Cook AJ, Lau KK, Raftery J, Yee CW, Jolly CJ . Incorporation of dUTP does not mediate mutation of A:T base pairs in Ig genes in vivo. Nucleic Acids Res 2010; 38: 8120\u20138130.","journal-title":"Nucleic Acids Res"},{"key":"BFleu2012294_CR36","doi-asserted-by":"publisher","first-page":"3578","DOI":"10.1073\/pnas.95.7.3578","volume":"95","author":"DA Kreutzer","year":"1998","unstructured":"Kreutzer DA, Essigmann JM . Oxidized, deaminated cytosines are a source of C --> T transitions in vivo. Proc Natl Acad Sci USA 1998; 95: 3578\u20133582.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2012294_CR37","doi-asserted-by":"publisher","first-page":"4278","DOI":"10.1093\/emboj\/20.15.4278","volume":"20","author":"H Nilsen","year":"2001","unstructured":"Nilsen H, Haushalter KA, Robins P, Barnes DE, Verdine GL, Lindahl T . Excision of deaminated cytosine from the vertebrate genome: role of the SMUG1 uracil-DNA glycosylase. EMBO J 2001; 20: 4278\u20134286.","journal-title":"EMBO J"},{"key":"BFleu2012294_CR38","doi-asserted-by":"publisher","first-page":"3189","DOI":"10.1158\/0008-5472.CAN-10-3224","volume":"71","author":"CA Eide","year":"2011","unstructured":"Eide CA, Adrian LT, Tyner JW, Mac Partlin M, Anderson DJ, Wise SC et al. The ABL switch control inhibitor DCC-2036 is active against the chronic myeloid leukemia mutant BCR-ABLT315I and exhibits a narrow resistance profile. Cancer Res 2011; 71: 3189\u20133195.","journal-title":"Cancer Res"},{"key":"BFleu2012294_CR39","doi-asserted-by":"publisher","first-page":"3746","DOI":"10.1182\/blood-2004-05-1941","volume":"104","author":"MO Nowicki","year":"2004","unstructured":"Nowicki MO, Falinski R, Koptyra M, Slupianek A, Stoklosa T, Gloc E et al. BCR\/ABL oncogenic kinase promotes unfaithful repair of the reactive oxygen species-dependent DNA double-strand breaks. Blood 2004; 104: 3746\u20133753.","journal-title":"Blood"},{"key":"BFleu2012294_CR40","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s11596-012-0057-z","volume":"32","author":"Y Xiao","year":"2012","unstructured":"Xiao Y, Zou P, Wang J, Song H, Zou J, Liu L . Lower phosphorylation of p38 MAPK blocks the oxidative stress-induced senescence in myeloid leukemic CD34(+)CD38 (\u2212) cells. J Huazhong Univ Sci Technolog Med Sci 2012; 32: 328\u2013333.","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"key":"BFleu2012294_CR41","doi-asserted-by":"publisher","first-page":"8935","DOI":"10.1038\/sj.onc.1205996","volume":"21","author":"HE Krokan","year":"2002","unstructured":"Krokan HE, Drablos F, Slupphaug G . Uracil in DNA--occurrence, consequences and repair. Oncogene 2002; 21: 8935\u20138948.","journal-title":"Oncogene"},{"key":"BFleu2012294_CR42","doi-asserted-by":"publisher","first-page":"3472","DOI":"10.1182\/blood.V99.9.3472","volume":"99","author":"S Branford","year":"2002","unstructured":"Branford S, Rudzki Z, Walsh S, Grigg A, Arthur C, Taylor K et al. High frequency of point mutations clustered within the adenosine triphosphate-binding region of BCR\/ABL in patients with chronic myeloid leukemia or Ph-positive acute lymphoblastic leukemia who develop imatinib (STI571) resistance. Blood 2002; 99: 3472\u20133475.","journal-title":"Blood"},{"key":"BFleu2012294_CR43","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1182\/blood-2002-09-2896","volume":"102","author":"S Branford","year":"2003","unstructured":"Branford S, Rudzki Z, Walsh S, Parkinson I, Grigg A, Szer J et al. Detection of BCR-ABL mutations in patients with CML treated with imatinib is virtually always accompanied by clinical resistance, and mutations in the ATP phosphate-binding loop (P-loop) are associated with a poor prognosis. Blood 2003; 102: 276\u2013283.","journal-title":"Blood"},{"key":"BFleu2012294_CR44","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/sj.thj.6200319","volume":"5","author":"HK Al-Ali","year":"2004","unstructured":"Al-Ali HK, Heinrich MC, Lange T, Krahl R, Mueller M, Muller C et al. High incidence of BCR-ABL kinase domain mutations and absence of mutations of the PDGFR and KIT activation loops in CML patients with secondary resistance to imatinib. Hematol J 2004; 5: 55\u201360.","journal-title":"Hematol J"},{"key":"BFleu2012294_CR45","first-page":"24","volume":"24","author":"S Willis","year":"2005","unstructured":"Willis S, Lange T, Demehri S, Otto S, Crossman L, Niederwieser D et al. High sensitivity detection of BCR-ABL kinase domain mutations in imatinib-naive patients: correlation with clonal cytogenetic evolution but not response to therapy. Blood 2005; 24: 24.","journal-title":"Blood"},{"key":"BFleu2012294_CR46","doi-asserted-by":"publisher","first-page":"6082","DOI":"10.1128\/MCB.02202-05","volume":"26","author":"IJ Griswold","year":"2006","unstructured":"Griswold IJ, MacPartlin M, Bumm T, Goss VL, O'Hare T, Lee KA et al. Kinase domain mutants of Bcr-Abl exhibit altered transformation potency, kinase activity, and substrate utilization, irrespective of sensitivity to imatinib. Mol Cell Biol 2006; 26: 6082\u20136093.","journal-title":"Mol Cell Biol"},{"key":"BFleu2012294_CR47","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1093\/jnci\/djk150","volume":"99","author":"X Jiang","year":"2007","unstructured":"Jiang X, Saw KM, Eaves A, Eaves C . Instability of BCR-ABL gene in primary and cultured chronic myeloid leukemia stem cells. J Natl Cancer Inst 2007; 99: 680\u2013693.","journal-title":"J Natl Cancer Inst"},{"key":"BFleu2012294_CR48","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1126\/science.1062538","volume":"293","author":"ME Gorre","year":"2001","unstructured":"Gorre ME, Mohammed M, Ellwood K, Hsu N, Paquette R, Rao PN et al. Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification. Science 2001; 293: 876\u2013880.","journal-title":"Science"},{"issue":"Suppl 1","key":"BFleu2012294_CR49","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3109\/10428194.2010.546912","volume":"52","author":"T Skorski","year":"2011","unstructured":"Skorski T . Chronic myeloid leukemia cells refractory\/resistant to tyrosine kinase inhibitors are genetically unstable and may cause relapse and malignant progression to the terminal disease state. Leuk Lymphoma 2011; 52 (Suppl 1): 23\u201329.","journal-title":"Leuk Lymphoma"},{"key":"BFleu2012294_CR50","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1038\/leu.2010.179","volume":"24","author":"H Grant","year":"2010","unstructured":"Grant H, Jiang X, Stebbing J, Foroni L, Craddock C, Griffiths M et al. Analysis of BCR-ABL1 tyrosine kinase domain mutational spectra in primitive chronic myeloid leukemia cells suggests a unique mutator phenotype. Leukemia 2010; 24: 1817\u20131821.","journal-title":"Leukemia"},{"key":"BFleu2012294_CR51","doi-asserted-by":"publisher","first-page":"5104","DOI":"10.1093\/nar\/gkh848","volume":"32","author":"Y Canitrot","year":"2004","unstructured":"Canitrot Y, Capp JP, Puget N, Bieth A, Lopez B, Hoffmann JS et al. DNA polymerase beta overexpression stimulates the Rad51-dependent homologous recombination in mammalian cells. Nucleic Acids Res 2004; 32: 5104\u20135112.","journal-title":"Nucleic Acids Res"},{"key":"BFleu2012294_CR52","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1182\/blood-2002-10-3207","volume":"102","author":"Y Canitrot","year":"2003","unstructured":"Canitrot Y, Falinski R, Louat T, Laurent G, Cazaux C, Hoffmann JS et al. p210 BCR\/ABL kinase regulates nucleotide excision repair (NER) and resistance to UV radiation. Blood 2003; 102: 2632\u20132637.","journal-title":"Blood"},{"key":"BFleu2012294_CR53","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1096\/fj.99-1063com","volume":"14","author":"Y Canitrot","year":"2000","unstructured":"Canitrot Y, Hoffmann JS, Calsou P, Hayakawa H, Salles B, Cazaux C . Nucleotide excision repair DNA synthesis by excess DNA polymerase beta: a potential source of genetic instability in cancer cells. Faseb J 2000; 14: 1765\u20131774.","journal-title":"Faseb J"},{"key":"BFleu2012294_CR54","doi-asserted-by":"publisher","first-page":"2676","DOI":"10.1038\/sj.onc.1202619","volume":"18","author":"Y Canitrot","year":"1999","unstructured":"Canitrot Y, Lautier D, Laurent G, Frechet M, Ahmed A, Turhan AG et al. Mutator phenotype of BCR\u2013ABL transfected Ba\/F3 cell lines and its association with enhanced expression of DNA polymerase beta. Oncogene 1999; 18: 2676\u20132680.","journal-title":"Oncogene"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu2012294.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2012294","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2012294.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T15:42:25Z","timestamp":1648741345000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2012294"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,9]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["BFleu2012294"],"URL":"https:\/\/doi.org\/10.1038\/leu.2012.294","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,9]]},"assertion":[{"value":"27 September 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2012","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2012","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2012","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}